Geila Rozen
Corporate Officer/Principal chez Rambam Medical Center
Profil
Geila Rozen is the founder of High Tech Lipids Ltd., which was founded in 2004.
She held the title of Clinical Researcher at the company.
Dr. Rozen's current job positions include being a Principal at Technion-Israel Institute of Technology, a Principal at The Hebrew University of Jerusalem, and a Principal at Rambam Medical Center.
Dr. Rozen obtained a doctorate degree from Technion-Israel Institute of Technology.
Postes actifs de Geila Rozen
| Sociétés | Poste | Début |
|---|---|---|
| Rambam Medical Center | Corporate Officer/Principal | 19/02/2010 |
| The Hebrew University of Jerusalem | Corporate Officer/Principal | 19/02/2010 |
| Technion-Israel Institute of Technology | Corporate Officer/Principal | 19/02/2010 |
Anciens postes connus de Geila Rozen
| Sociétés | Poste | Fin |
|---|---|---|
High Tech Lipids Ltd.
 High Tech Lipids Ltd. Pharmaceuticals: MajorHealth Technology High Tech Lipids Ltd. develops lipid emulsions for infants and adults. It offers neonatal emulsions and immuno-nutrition lipids for chemotherapy patients, AIDS patients and other specific categories of surgical and critical care patients. The firm serves various sectors of the total parenteral nutrition (TPN) market, such as TPN manufacturers, healthcare providers and TPN patients. The company was founded by Geila Rozen and Irit Shochat in 2004 and is headquartered in D.N. Misgav, Israel. | Fondateur | - |
Formation de Geila Rozen
| Technion-Israel Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
High Tech Lipids Ltd.
High Tech Lipids Ltd. Pharmaceuticals: MajorHealth Technology High Tech Lipids Ltd. develops lipid emulsions for infants and adults. It offers neonatal emulsions and immuno-nutrition lipids for chemotherapy patients, AIDS patients and other specific categories of surgical and critical care patients. The firm serves various sectors of the total parenteral nutrition (TPN) market, such as TPN manufacturers, healthcare providers and TPN patients. The company was founded by Geila Rozen and Irit Shochat in 2004 and is headquartered in D.N. Misgav, Israel. | Health Technology |
| Rambam Medical Center |
